Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
car-t targeted cd19/cd20/cd22/cd30 (1 trial)
cd22 car-t cells (1 trial)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)